Growth Hormone Peptide Comparison

The complete GH secretagogue guide — GHRH pathway vs. Ghrelin pathway, dual-pathway synergy, and research recommendations.

Bottom line: Growth hormone secretagogues work through two receptor pathways: GHRH (controls pulse amplitude — CJC-1295, Mod GRF 1-29, Sermorelin, Tesamorelin) and Ghrelin (controls pulse frequency — Ipamorelin, GHRP-2, GHRP-6, Hexarelin). Combining one from each pathway produces 3–5× greater GH release than either alone. The gold standard combination is Mod GRF 1-29 + Ipamorelin — the most selective pairing with no cortisol, prolactin, or appetite effects.

Two Pathways, One Goal: GH secretagogues work through two main receptor systems on pituitary somatotrophs. GHRH-pathway peptides (CJC-1295, Mod GRF, Sermorelin, Tesamorelin) control GH pulse amplitude. Ghrelin-pathway peptides (Ipamorelin, GHRP-2, GHRP-6, Hexarelin) control pulse frequency. Combining both produces 3–5× greater GH release than either alone.

GHRH-Pathway Peptides (Amplitude)

PropertyCJC-1295 w/DACMod GRF 1-29SermorelinTesamorelin
Half-Life6–8 days~30 minutes~10–20 minutes~30–40 minutes
GH ReleaseSustained (continuous)Sharp pulse (pulsatile)Sharp pulseSharp pulse
DPP-IV ResistantYes (DAC + mods)Yes (4 AA substitutions)No (rapid degradation)No
FDA StatusResearch onlyResearch onlyApproved (Geref)Approved (Egrifta)
Special FeatureLongest duration — albumin-boundMost widely used — precise pulsingOriginal GHRH analog — FDA approvedFDA approved for visceral fat
Starting Price$49 (5mg)$39 (5mg)$39 (5mg)$89 (2mg)

Ghrelin-Pathway Peptides (Frequency)

PropertyIpamorelinGHRP-2GHRP-6Hexarelin
GH StrengthModerateStrong (highest GHRP)StrongVery strong (strongest)
CortisolNoneMildModerateModerate-High
ProlactinNoneMildModerateHigh
AppetiteNoneMildStrongModerate
SelectivityMost selective (GH only)ModerateLeast selectiveLow
Special FeatureCleanest GH release — no side hormonesStrongest GH pulse (2–3×)Strongest appetite stimulationStrongest total GH output + cardioprotective
Starting Price$39 (5mg)$39 (5mg)$39 (5mg)$39 (5mg)

Dual-Pathway Combination Profiles

Mod GRF 1-29 + Ipamorelin

Gold standard — pulsatile GH, clean selectivity. No cortisol, prolactin, or appetite effects. Most widely researched combination.

Mod GRF 1-29 + GHRP-2

Maximum GH amplitude — strongest pulse with mild cortisol/prolactin. Best for researchers prioritizing peak GH output.

CJC-1295 w/DAC + Ipamorelin

Sustained elevation — 6–8 day continuous GH release. Convenient once-weekly dosing with clean selectivity.

Mod GRF 1-29 + GHRP-6

GH + appetite stimulation — strong ghrelin/hunger effects. Useful when appetite increase is a desired research outcome.

Mod GRF 1-29 + Hexarelin

Strongest total GH output — least selective, significant cortisol and prolactin increase. Unique cardioprotective properties.

Which Combination Is Right?

Research ScenarioRecommendation
Clean, selective GH researchMod GRF 1-29 + Ipamorelin
Maximum GH pulse amplitudeMod GRF 1-29 + GHRP-2
Visceral/liver fat researchTesamorelin (± Ipamorelin)
Sustained GH elevationCJC-1295 w/DAC (± Ipamorelin)
Cardiac protection researchHexarelin
Budget-friendly entry pointSermorelin + Ipamorelin

GH Peptide FAQ

What is the best growth hormone peptide combination?
Mod GRF 1-29 + Ipamorelin is the most widely researched and recommended combination. It provides synergistic GH release through two independent pathways (GHRH-R + GHS-R) while maintaining the cleanest selectivity profile — no increases in cortisol, prolactin, or appetite.
Why is Ipamorelin the 'cleanest' GH peptide?
Ipamorelin is the only GH secretagogue that selectively stimulates growth hormone release without increasing cortisol, prolactin, or triggering appetite stimulation. This makes it ideal for research where isolating GH effects is important.
Why use GH peptides instead of direct growth hormone?
GH secretagogues preserve the body's natural pulsatile GH release pattern, which is physiologically important. They stimulate endogenous production rather than replacing it, maintain feedback loops, and have a more favorable safety profile for research applications.
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC (Drug Affinity Complex) has a 6–8 day half-life via albumin binding — it produces sustained, continuous GH elevation. Mod GRF 1-29 (without DAC) has a ~30-minute half-life, producing sharp pulsatile GH release that more closely mimics natural patterns.
What is dual-pathway synergy?
When GHRH-pathway (amplitude) and Ghrelin-pathway (frequency) peptides are combined, they create a synergistic effect — GH output is 3–5× greater than either peptide alone. This is because they activate two independent receptor systems on pituitary somatotrophs simultaneously.
Can I use MK-677 instead of injectable GH peptides?
MK-677 (Ibutamoren) is an oral GH secretagogue that activates GHS-R1a. It offers convenience but has a very long half-life (~24 hours), causing sustained GH/IGF-1 elevation rather than natural pulses. It also increases appetite and may affect insulin sensitivity.